Merck Sharp & Dohme drops lawsuit over Januvia patent
Healthcare 2020-10-09 2:25 pm By Cat Fredenburgh | Melbourne
Please login to bookmark Close

Merck Sharp & Dohme has dropped a lawsuit brought against a unit of Indian generic manufacturer Lupin for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Januvia and Janumet.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au